Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00733902 · ClinicalTrials.gov registry record · Phase 3
Tanezumab in Osteoarthritis of the Knee
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 697
- Enrollment target
NCT00733902: Completed Phase 3 study, sponsored by Pfizer.
NCT00733902 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 697 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (10% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00733902, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 697 participants
- Enrollment target
Study Summary
Test the efficacy and safety of 3 doses in Osteoarthritis of the knee in patients.
Primary Outcome
WOMAC: Self-administered, disease-specific questionnaire which assesses clinically important, participant-relevant symptoms for pain, stiffness and physical function in participants with osteoarthritis (OA). WOMAC pain subscale is a 5-item questionnaire used to assess the amount of pain experienced due to osteoarthritis in index knee during past 48 hours. It is calculated as mean of the scores from 5 individual questions, each scored on a numerical rating scale (NRS) of 0 (no pain) to 10 (extrem
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL tanezumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 697 participants |
| Start Date | 2008-09-15 |
| Est. Completion | 2010-01-14 |
| Phase | Phase 3 |
What the finished NCT00733902 record still lists
NCT00733902 is an interventional study that assigns participants to a tested intervention. The registered 697 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (10% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00733902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00733902 about?
NCT00733902 is a clinical study titled "Tanezumab in Osteoarthritis of the Knee". Test the efficacy and safety of 3 doses in Osteoarthritis of the knee in patients.
What is the current status of trial NCT00733902?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 697 participants. The study started on 2008-09-15. Estimated completion is 2010-01-14.
What interventions are being tested in trial NCT00733902?
The interventions under investigation include: Placebo (BIOLOGICAL), tanezumab (BIOLOGICAL).
Who is sponsoring clinical trial NCT00733902?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00733902's enrollment target sits among peer trials
697 518th of 2000 higher than 1,483 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03136094 · 698 participants · NA
Suicide in Urban Natives: Detection and Networks to Combat Events
- NCT04928846 · 698 participants · Phase 3
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- NCT05943535 · 698 participants · Phase 3
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- NCT07187115 · 699 participants · NA
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI